Patients Returning Home After Discharge From HospitalSENTIPATNCT01769261
Sentinel Patients: Value of an Information System Collecting Patient's Own Report on His Healthcare Management
A study testing eligible, Internet, eligibles, telephone and non eligibles in people with Patients Returning Home After Discharge From Hospital, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.
Trial summary
"Evolution of patient's health after hospital discharge is poorly documented. The investigators hypothesize that information of good quality on this concern might be accessible at a relatively low cost from patients, further referred to as sentinel patients, who would voluntary report their health evolution on a… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Patients Returning Home After Discharge From Hospital
- What is being tested?
- eligible, Internet, eligibles, telephone and non eligibles
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 2,090 participants
- Where
- 1 siteFrance
- Study dates
- Feb 2013to Oct 2014
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- adult (age ≥ 18) patients, with a short-term (1day), mid-term (1week) or conventional hospitalization, scheduled or unscheduled,
- having signified their non opposition to participate in the study,
- with no cognitive deficit or behavioral trouble,
- speaking and writing French,
- not leaving hospital against medical advice,
- returning home after hospital discharge,
- having at their disposal (eligible patients: sentinel and telephone arms) or not (non eligible arm) an internet connection at home,
Who cannot join
- being already included in the study because of a previous hospital stay: all inclusions will involve distinct patients,
- participating in another biomedical research in the period of 45 days following their hospital discharge,
- homeless,
- whose hospital stay is not registered under patient real name (anonymous hospitalization),
- opposed to their participation in the study.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Sentinel Patients : Value of an Information System Collecting Patient's Own Report on His Healthcare Management. Application to the Detection of Adverse Events After Hospital Discharge.
"Evolution of patient's health after hospital discharge is poorly documented. The investigators hypothesize that information of good quality on this concern might be accessible at a relatively low cost from patients, further referred to as sentinel patients, who would voluntary report their health evolution on a dedicated web site.
The SENTIPAT study presents as a proof of concept study. It will collect patient's health evolution during a post-hospital discharge period of 45 days. The study presents as a randomized trial comparing patients' reports issued from two different methods in a patient population returning home after hospital discharge and having at disposal an internet access at home:
in the " internet " arm, sentinel patients will be solicited to directly report their post-discharge health evolution on a website especially devoted for collecting these data while in the " telephone " arm, the same items will be collected through a telephone interview 45 days after hospital discharge. Investigations will focus on post-discharge adverse events and will include appearance/worsening of symptoms, healthcare resources utilization, quality of life, and patients' satisfaction."
Read the detailed description
Main lines of the study. Evolution of patient's health after hospital discharge is poorly documented. We hypothesize that information of good quality on this concern might be accessible at a relatively low cost from patients, further referred to as sentinel patients, who would voluntary report their health evolution on a dedicated website.
The SENTIPAT study presents as a proof of concept study. It will collect patient's health evolution during a post-hospital discharge period of 45 days. The study presents as a randomized trial comparing patients' reports issued from two different methods in patients returning home after hospital discharge and having at disposal an internet connection available at home (further referred to as "eligible patients"):
in the " Internet " arm, sentinel patients will be solicited to directly report their data on a web-site especially devoted for collecting these data while in the " Telephone " arm, the same data will be collected through a telephone interview 45 days after hospital discharge. Investigations will concern appearance/worsening of symptoms, healthcare resources utilization, quality of life, and patients' satisfaction.
Adverse events. An adverse event is defined as non-related to patient's disease but associated with a default or excess of care. A clinically significant event is defined as one of the following events: new symptom(s) appearing after hospital discharge or worsening for symptoms present at hospital discharge, unscheduled rehospitalization or consultation whatever the reason for it, death (patients lost to follow-up will be investigated for their vital status). A validated event is an event considered as adverse by a validation medical committee, blind in terms of the source declaration whatever the source (sentinel patients or telephone survey). In addition, the committee will classify each validated event according to a criterion of avoidability.
Design. The main hypothesis of the study is that the risk of clinically significant validated adverse event is at least as well reported by volunteer patients (sentinel patients: Internet arm) as by a specific cohort follow-up (Telephone survey arm). SENTIPAT presents as a multi-center (five departments within the same hospital) non-inferiority randomized trial comparing the internet and telephone arms. Enrollment of eligible patients will be performed on the basis of consecutive such patients being discharged from hospital in the participating departments. Internet/Telephone randomization of eligible patients is stratified per department.
In addition, in order to estimate the distance of representativeness of eligible patients, a substantial number of patients having no internet access at their home (further referred to as "non eligible patients") will also be recruited and compose a third arm where patients are not randomized: all non eligible patients will be investigated via a telephone interview 45 days after discharge, just as the patients in the Telephone arm. No intermediate analysis was planned.
Primary objective. The primary outcome criterion is the proportion of patients reporting at least a "clinically significant validated" adverse event (see definition below) occurring during the period of 45 days after hospital discharge. The observed proportions in the Internet and Telephone arms will be compared.
Secondary objectives.
The secondary objectives include:
- related to the primary criterion:
- Nature, chronology, severity and avoidability of the clinically significant adverse events
- Proportion of validated adverse events issued from the Internet and Telephone reports
- Association between adverse event occurrence and a) patient's perceived quality of care/health (SF-36 questionnaire, perceived health state-visual analogic scale-at admission, discharge, and 45 days after discharge), and b) post-discharge continuity of care (information transmitted to the post-discharge referent physician(s) of the patient).
- related to the proof of concept for sentinel patients:
- Proportion of eligible patients, active sentinels, their characteristics as compared to the patient population hospitalized in the departments participating in the study.
- Rate for internet equipment and utilization.
- Rate of participation and completion of the questionnaires.
- Estimate the costs of the sentinel patients' information system and compare these costs to those of a specific cohort survey.
- related to the objective of assessing the representativeness distance of eligible patients:
- Comparing the whole set of variables at baseline (i.e. inclusion, day of hospital discharge) between non eligible and eligible patients (e.g., socio-demographic characteristics-age, sex, social support-, hospital stay characteristics-reason, length, medication prescribed at discharge-).
- Comparing the rate of adverse events avoidable or not between the three arms (Non Eligible, Eligible-Internet, Eligible-Telephone).
- Making the above comparison in relation with hospital stay features, post-discharge other features (i.e. excluding post-discharge adverse events).
- Measuring patient's satisfaction (SAPHORA-MCO© questionnaire) and quality of life. The observed measures in the three arms will be compared.
- Description of the healthcare resources utilized after hospital discharge (consultations including their delay).
Sample size. Calculation was based on non-inferiority between two collection sources (Internet vs Telephone) of clinically significant adverse events in eligible patients. According to Forster et al (Ann Intern Med 2003, Cmaj 2004) we retained the target of 20% patients presenting at least such an event, and an equivalence limit of 5%. A 80% power is obtained through the inclusion of 2050 patients, 1025 in the Internet arm, and 1025 in the Telephone arm. In parallel, we planned to enroll 500 non eligible patients. The protocol plans the total enrollment of 2550 patients, with 205, 205, and 100 patients in the Internet, Telephone and Non Eligible arms, respectively, in each of the five participating departments.
Statistical methods. The results of the study will be presented according to CONSORT recommendations adapted to non-inferiority trials. Patients of the Internet and Telephone arms will constitute the sample for all comparisons between internet and telephone, which constitute the primary objective of the study. This same population will be considered for the comparative cost study. Eligible vs non eligible patients will constitute the sample for studying the representativeness of eligible patients to be sentinel vs non eligible patients. Primary analysis will be conducted using an "intention to watch over" strategy, applying the rule "lost to follow-up implies absence of event in the corresponding patients". Such an imputation of missing values is the most appropriate for rejecting the non-inferiority hypothesis in case of an important imbalance in the rate of lost to follow-up between the Internet and the Telephone groups. However, intention to treat is not usual in non-inferiority trials. Therefore sensitivity analyses restricted to patients with follow-up data will also be conducted.
Analysis of the primary outcome will be made by determining the bilateral 95% confidence interval of the difference in the proportion of patients with at least a validated clinically significant adverse event between the Internet and the Telephone groups, and by excluding the value of 5% of this interval.
Considering secondary analyses, within each of the participating departments, between group comparisons will be made using a Mann-Whitney or a Kruskall-Wallis test for quantitative variables, using Fisher's exact test for categorical variables, and using the Log-Rank test for duration variables. Considering the whole departments, The Friedman test will be used for quantitative variables and the Cochran-Mantel-Haenszel test will be used for categorical variables. Generalized linear regression models will be used for multivariate analyses of the criteria within the participating departments (multiple linear modeling, logistic regression, survival proportional hazards model) and generalized estimating equations modeling (with exchangeable correlations) will be used on departments' pooled data. Analyses will be conducted using SAS and R software.
The primary perspective retained for the cost analysis is the hospital perspective. A more complete analysis using a societal perspective might be considered later, including opportunity costs supported by sentinel patients. Most cost values will be directly issued from the study and all those involving horary tasks will be valued according to the human capital approach. The costs of the sentinel surveillance will include the costs associated to the development and the maintenance of the associated information system. The costs of the telephone survey will include those related to call management organization and to operator human time. Time spent for patient selection, inclusion, collection of non-opposition agreement, event coding, validation, and data analysis will be measured in the two groups of patients. Cost data will be balanced with participation rates and with questionnaires' completion and quality rates. In the end, costs for the Internet and Telephone strategies will be contrasted with the corresponding detection rates of adverse events. The incremental cost-effectiveness ratio of the Telephone strategy vs a patient's sentinel website will be estimated. Two situations will be considered: either limited to the study, the website being non-perennial, or considering a more intensive use: for example, models will explore wider multi-center uses of the website and longer periods than that that of the study (the latters implying an increase in maintenance costs but also a return of investment for the website development). The cost-effectiveness ratios in the two situations may substantially differ in the two situations.
- Being tested
- eligible, Internet, eligibles, telephone, non eligibles
- Keywords
- quality of health care, continuity of patient care, adverse effects, outcome and process assessment (health care)
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
eligible, InternetOther
Patients randomized in the internet arm. They will directly complete their health evolution after hospital discharge via the internet.
eligibles, telephoneOther
Patients randomized in the telephone arm. Their health evolution after hospital discharge will be documented via a telephone interview at J45 after hospital discharge
non eligiblesOther
Patients who do not have an internet access at home. Their health evolution after hospital discharge will be documented via a telephone interview at J45. after hospital discharge.
| Study group | Role | What they receive |
|---|---|---|
| Internet, eligible patients | Experimental | Patients randomized in the internet arm. They will directly complete their health evolution after hospital discharge via the internet. Receives: Other: eligible, Internet |
| Telephone, eligible patients | Active comparator | Patients randomized in the telephone arm. Their health evolution after hospital discharge will be documented via a telephone interview at J45 after hospital discharge.. Receives: Other: eligibles, telephone |
| " Non eligible" patients | Other | Patients who do not have an internet access at home. Their health evolution after hospital discharge will be documented via a telephone interview at J45. after hospital discharge. Receives: Other: non eligibles |
What is being measured
The primary outcome is the main question the study is designed to answer.
proportion of patients reporting at least a clinically significant adverse event (as judged by the validation committee) occuring in the period of 45 days after hospital discharge.
Measured: from hospital discharge (D0) until 45 days later (D45)
Secondary outcomes (1)
Nature, chronology, severity and avoidability of adverse events. Other second outcome measures are mentioned in the detailed description of the study.
Measured: from hospital discharge (D0) until 45 days later (D45)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Jan 2013 (estimated)
- Study startFeb 2013
- Primary completionOct 2014
- Study completionOct 2014
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for Patients Returning Home After Discharge From HospitalStudies of the same condition, open and under way.
- More trials run by Assistance Publique - Hôpitaux de ParisThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 2,090 participants (actual)
Sponsor and investigators
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- Sponsor type
- University, hospital or other
- Collaborators
- Institut National de la Santé Et de la Recherche Médicale, France, Pierre and Marie Curie University
- Responsible party
- Sponsor
- Investigators
- Fabrice Carrat, MD, PhD, Principal investigator, Assistance Publique
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01769261
- Sponsor's protocol ID
- AOM09213 - K081204
- Acronym
- SENTIPAT
- Status last verified
- Jul 2016
- First submitted
- 14 Jan 2013
- Last updated
- 2 Aug 2016
- Results posted
- No
- Data monitoring committee
- No
Publications
Acma A, Carrat F, Hejblum G. Comparing SF-36 Scores Collected Through Web-Based Questionnaire Self-completions and Telephone Interviews: An Ancillary Study of the SENTIPAT Multicenter Randomized Controlled Trial. J Med Internet Res. 2022 Mar 10;24(3):e29009. doi: 10.2196/29009.
PubMed 35266869Feldman SF, Lapidus N, Cosnes J, Tiret E, Fonquernie L, Cabane J, Chazouilleres O, Surgers L, Beaussier M, Valleron AJ, Carrat F, Hejblum G. Comparing Inpatient Satisfaction Collected via a Web-Based Questionnaire Self-Completion and Through a Telephone Interview: An Ancillary Study of the SENTIPAT Randomized Controlled Trial. J Med Internet Res. 2017 Aug 23;19(8):e293. doi: 10.2196/jmir.7061.
PubMed 28835354Couturier B, Carrat F, Hejblum G; SENTIPAT Study Group. Comparing Patients' Opinions on the Hospital Discharge Process Collected With a Self-Reported Questionnaire Completed Via the Internet or Through a Telephone Survey: An Ancillary Study of the SENTIPAT Randomized Controlled Trial. J Med Internet Res. 2015 Jun 24;17(6):e158. doi: 10.2196/jmir.4379.
PubMed 26109261
Study at a glance
From the registry record, last updated by the sponsor on 2 Aug 2016. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Sentinel Patients : Value of an Information System Collecting Patient's Own Report on His Healthcare Management. Application to the Detection of Adverse Events After Hospital Discharge.
- ClinicalTrials.gov ID
- NCT01769261
- Acronym / sponsor ID
- SENTIPAT / AOM09213 - K081204
- Keywords
- quality of health care, continuity of patient care, adverse effects, outcome and process assessment (health care)
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 2,090 participants (actual)
- Lead sponsor
- Assistance Publique - Hôpitaux de ParisUniversity, hospital or other
- Collaborators
- Institut National de la Santé Et de la Recherche Médicale, France, Pierre and Marie Curie University
- Study start
- Feb 2013
- Primary completion
- Oct 2014 (actual)
- Study completion
- Oct 2014 (actual)
- First posted
- 16 Jan 2013 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
"Evolution of patient's health after hospital discharge is poorly documented. The investigators hypothesize that information of good quality on this concern might be accessible at a relatively low cost from patients, further referred to as sentinel patients, who would voluntary report their health evolution on a dedicated web site.
The SENTIPAT study presents as a proof of concept study. It will collect patient's health evolution during a post-hospital discharge period of 45 days. The study presents as a randomized trial comparing patients' reports issued from two different methods in a patient population returning home after hospital discharge and having at disposal an internet access at home:
in the " internet " arm, sentinel patients will be solicited to directly report their post-discharge health evolution on a website especially devoted for collecting these data while in the " telephone " arm, the same items will be collected through a telephone interview 45 days after hospital discharge. Investigations will focus on post-discharge adverse events and will include appearance/worsening of symptoms, healthcare resources utilization, quality of life, and patients' satisfaction."
Detailed description
Main lines of the study. Evolution of patient's health after hospital discharge is poorly documented. We hypothesize that information of good quality on this concern might be accessible at a relatively low cost from patients, further referred to as sentinel patients, who would voluntary report their health evolution on a dedicated website.
The SENTIPAT study presents as a proof of concept study. It will collect patient's health evolution during a post-hospital discharge period of 45 days. The study presents as a randomized trial comparing patients' reports issued from two different methods in patients returning home after hospital discharge and having at disposal an internet connection available at home (further referred to as "eligible patients"):
in the " Internet " arm, sentinel patients will be solicited to directly report their data on a web-site especially devoted for collecting these data while in the " Telephone " arm, the same data will be collected through a telephone interview 45 days after hospital discharge. Investigations will concern appearance/worsening of symptoms, healthcare resources utilization, quality of life, and patients' satisfaction.
Adverse events. An adverse event is defined as non-related to patient's disease but associated with a default or excess of care. A clinically significant event is defined as one of the following events: new symptom(s) appearing after hospital discharge or worsening for symptoms present at hospital discharge, unscheduled rehospitalization or consultation whatever the reason for it, death (patients lost to follow-up will be investigated for their vital status). A validated event is an event considered as adverse by a validation medical committee, blind in terms of the source declaration whatever the source (sentinel patients or telephone survey). In addition, the committee will classify each validated event according to a criterion of avoidability.
Design. The main hypothesis of the study is that the risk of clinically significant validated adverse event is at least as well reported by volunteer patients (sentinel patients: Internet arm) as by a specific cohort follow-up (Telephone survey arm). SENTIPAT presents as a multi-center (five departments within the same hospital) non-inferiority randomized trial comparing the internet and telephone arms. Enrollment of eligible patients will be performed on the basis of consecutive such patients being discharged from hospital in the participating departments. Internet/Telephone randomization of eligible patients is stratified per department.
In addition, in order to estimate the distance of representativeness of eligible patients, a substantial number of patients having no internet access at their home (further referred to as "non eligible patients") will also be recruited and compose a third arm where patients are not randomized: all non eligible patients will be investigated via a telephone interview 45 days after discharge, just as the patients in the Telephone arm. No intermediate analysis was planned.
Primary objective. The primary outcome criterion is the proportion of patients reporting at least a "clinically significant validated" adverse event (see definition below) occurring during the period of 45 days after hospital discharge. The observed proportions in the Internet and Telephone arms will be compared.
Secondary objectives.
The secondary objectives include:
- related to the primary criterion:
- Nature, chronology, severity and avoidability of the clinically significant adverse events
- Proportion of validated adverse events issued from the Internet and Telephone reports
- Association between adverse event occurrence and a) patient's perceived quality of care/health (SF-36 questionnaire, perceived health state-visual analogic scale-at admission, discharge, and 45 days after discharge), and b) post-discharge continuity of care (information transmitted to the post-discharge referent physician(s) of the patient).
- related to the proof of concept for sentinel patients:
- Proportion of eligible patients, active sentinels, their characteristics as compared to the patient population hospitalized in the departments participating in the study.
- Rate for internet equipment and utilization.
- Rate of participation and completion of the questionnaires.
- Estimate the costs of the sentinel patients' information system and compare these costs to those of a specific cohort survey.
- related to the objective of assessing the representativeness distance of eligible patients:
- Comparing the whole set of variables at baseline (i.e. inclusion, day of hospital discharge) between non eligible and eligible patients (e.g., socio-demographic characteristics-age, sex, social support-, hospital stay characteristics-reason, length, medication prescribed at discharge-).
- Comparing the rate of adverse events avoidable or not between the three arms (Non Eligible, Eligible-Internet, Eligible-Telephone).
- Making the above comparison in relation with hospital stay features, post-discharge other features (i.e. excluding post-discharge adverse events).
- Measuring patient's satisfaction (SAPHORA-MCO© questionnaire) and quality of life. The observed measures in the three arms will be compared.
- Description of the healthcare resources utilized after hospital discharge (consultations including their delay).
Sample size. Calculation was based on non-inferiority between two collection sources (Internet vs Telephone) of clinically significant adverse events in eligible patients. According to Forster et al (Ann Intern Med 2003, Cmaj 2004) we retained the target of 20% patients presenting at least such an event, and an equivalence limit of 5%. A 80% power is obtained through the inclusion of 2050 patients, 1025 in the Internet arm, and 1025 in the Telephone arm. In parallel, we planned to enroll 500 non eligible patients. The protocol plans the total enrollment of 2550 patients, with 205, 205, and 100 patients in the Internet, Telephone and Non Eligible arms, respectively, in each of the five participating departments.
Statistical methods. The results of the study will be presented according to CONSORT recommendations adapted to non-inferiority trials. Patients of the Internet and Telephone arms will constitute the sample for all comparisons between internet and telephone, which constitute the primary objective of the study. This same population will be considered for the comparative cost study. Eligible vs non eligible patients will constitute the sample for studying the representativeness of eligible patients to be sentinel vs non eligible patients. Primary analysis will be conducted using an "intention to watch over" strategy, applying the rule "lost to follow-up implies absence of event in the corresponding patients". Such an imputation of missing values is the most appropriate for rejecting the non-inferiority hypothesis in case of an important imbalance in the rate of lost to follow-up between the Internet and the Telephone groups. However, intention to treat is not usual in non-inferiority trials. Therefore sensitivity analyses restricted to patients with follow-up data will also be conducted.
Analysis of the primary outcome will be made by determining the bilateral 95% confidence interval of the difference in the proportion of patients with at least a validated clinically significant adverse event between the Internet and the Telephone groups, and by excluding the value of 5% of this interval.
Considering secondary analyses, within each of the participating departments, between group comparisons will be made using a Mann-Whitney or a Kruskall-Wallis test for quantitative variables, using Fisher's exact test for categorical variables, and using the Log-Rank test for duration variables. Considering the whole departments, The Friedman test will be used for quantitative variables and the Cochran-Mantel-Haenszel test will be used for categorical variables. Generalized linear regression models will be used for multivariate analyses of the criteria within the participating departments (multiple linear modeling, logistic regression, survival proportional hazards model) and generalized estimating equations modeling (with exchangeable correlations) will be used on departments' pooled data. Analyses will be conducted using SAS and R software.
The primary perspective retained for the cost analysis is the hospital perspective. A more complete analysis using a societal perspective might be considered later, including opportunity costs supported by sentinel patients. Most cost values will be directly issued from the study and all those involving horary tasks will be valued according to the human capital approach. The costs of the sentinel surveillance will include the costs associated to the development and the maintenance of the associated information system. The costs of the telephone survey will include those related to call management organization and to operator human time. Time spent for patient selection, inclusion, collection of non-opposition agreement, event coding, validation, and data analysis will be measured in the two groups of patients. Cost data will be balanced with participation rates and with questionnaires' completion and quality rates. In the end, costs for the Internet and Telephone strategies will be contrasted with the corresponding detection rates of adverse events. The incremental cost-effectiveness ratio of the Telephone strategy vs a patient's sentinel website will be estimated. Two situations will be considered: either limited to the study, the website being non-perennial, or considering a more intensive use: for example, models will explore wider multi-center uses of the website and longer periods than that that of the study (the latters implying an increase in maintenance costs but also a return of investment for the website development). The cost-effectiveness ratios in the two situations may substantially differ in the two situations.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Internet, eligible patients | Experimental | Other: eligible, InternetPatients randomized in the internet arm. They will directly complete their health evolution after hospital discharge via the internet. |
| Telephone, eligible patients | Active comparator | Other: eligibles, telephonePatients randomized in the telephone arm. Their health evolution after hospital discharge will be documented via a telephone interview at J45 after hospital discharge.. |
| " Non eligible" patients | Other | Other: non eligiblesPatients who do not have an internet access at home. Their health evolution after hospital discharge will be documented via a telephone interview at J45. after hospital discharge. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (7 listed)
- adult (age ≥ 18) patients, with a short-term (1day), mid-term (1week) or conventional hospitalization, scheduled or unscheduled,
- having signified their non opposition to participate in the study,
- with no cognitive deficit or behavioral trouble,
- speaking and writing French,
- not leaving hospital against medical advice,
Key exclusion criteria (5 listed)
- being already included in the study because of a previous hospital stay: all inclusions will involve distinct patients,
- participating in another biomedical research in the period of 45 days following their hospital discharge,
- homeless,
- whose hospital stay is not registered under patient real name (anonymous hospitalization),
- opposed to their participation in the study.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| eligible, InternetPatients randomized in the internet arm. They will directly complete their health evolution after hospital discharge via the internet. | Other | Internet, eligible patients |
| eligibles, telephonePatients randomized in the telephone arm. Their health evolution after hospital discharge will be documented via a telephone interview at J45 after hospital discharge | Other | Telephone, eligible patients |
| non eligiblesPatients who do not have an internet access at home. Their health evolution after hospital discharge will be documented via a telephone interview at J45. after hospital discharge. | Other | " Non eligible" patients |
Primary outcome
proportion of patients reporting at least a clinically significant adverse event (as judged by the validation committee) occuring in the period of 45 days after hospital discharge.
Time frame: from hospital discharge (D0) until 45 days later (D45)
1 secondary outcome
Nature, chronology, severity and avoidability of adverse events. Other second outcome measures are mentioned in the detailed description of the study.
Time frame: from hospital discharge (D0) until 45 days later (D45)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Aug 2016.
- Derived from this study: PubMed 35266869Acma A, Carrat F, Hejblum G. Comparing SF-36 Scores Collected Through Web-Based Questionnaire Self-completions and Telephone Interviews: An Ancillary Study of the SENTIPAT Multicenter Randomized Controlled Trial. J Med Internet Res. 2022 Mar 10;24(3):e29009. doi: 10.2196/29009.
- Derived from this study: PubMed 28835354Feldman SF, Lapidus N, Cosnes J, Tiret E, Fonquernie L, Cabane J, Chazouilleres O, Surgers L, Beaussier M, Valleron AJ, Carrat F, Hejblum G. Comparing Inpatient Satisfaction Collected via a Web-Based Questionnaire Self-Completion and Through a Telephone Interview: An Ancillary Study of the SENTIPAT Randomized Controlled Trial. J Med Internet Res. 2017 Aug 23;19(8):e293. doi: 10.2196/jmir.7061.
- Derived from this study: PubMed 26109261Couturier B, Carrat F, Hejblum G; SENTIPAT Study Group. Comparing Patients' Opinions on the Hospital Discharge Process Collected With a Self-Reported Questionnaire Completed Via the Internet or Through a Telephone Survey: An Ancillary Study of the SENTIPAT Randomized Controlled Trial. J Med Internet Res. 2015 Jun 24;17(6):e158. doi: 10.2196/jmir.4379.
- Couturier et al, J Med Internet Res 2015;17(6):e158Link provided by the sponsor.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Fabrice Carrat, MD, PhD principal investigator
Assistance Publique
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing eligible, Internet, eligibles, telephone and non eligibles in people with Patients Returning Home After Discharge From Hospital, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 2 Aug 2016. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
proportion of patients reporting at least a clinically significant adverse event (as judged by the validation committee) occuring in the period of 45 days after hospital discharge. (time frame: from hospital discharge (D0) until 45 days later (D45)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT01769261, which also lists 3 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Aug 2016.